https://doi.org/10.4081/hmr.v1i2.223

Re-evaluation of response criteria in chronic lymphocytic leukemia and the significance of minimal residual disease

Vol. 1 No. 2: Is Elimination of Minimal Residual Disease Significant for the Outcome of CLL? The Role of Alemtuzumab
Published: May 28, 2009
Abstract Views: 201
PDF: 755
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Michael Hallek
support@pagepress.org
Chronic lymphocytic leukemia (CLL) is one of the most common lymphoid malignancies in the developed world, affecting approximately 120,000 people annually in the USA and Europe. The disease has a very variable clinical course; many patients survive for decades without requiring treatment and die of unrelated causes, whereas other patients develop more aggressive forms of the disease that lead to an early death. Traditionally, the approach to the management of CLL has been watchful waiting, with clinical staging (Rai or Binet) providing limited prognostic information

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Hallek, M. (2009). Re-evaluation of response criteria in chronic lymphocytic leukemia and the significance of minimal residual disease. Hematology Meeting Reports (formerly Haematologica Reports), 1(2), 1–4. https://doi.org/10.4081/hmr.v1i2.223
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).